Trials / Completed
CompletedNCT03375957
Sensitization Study of ATx201 in Healthy Volunteers
A Single-Site Study To Evaluate the Sensitization Potential of Topically Applied ATx201 in Healthy Human Volunteers
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 240 (actual)
- Sponsor
- UNION therapeutics · Industry
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
This is a Phase I, single-site study to evaluate the sensitization potential of topically applied ATx201 GEL, 2% and 4%, along with a placebo control, in healthy human subjects.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | ATx201 | two hundred microliters (200 μL) of test article applied to the test site areas of the upper outer arms |
| DRUG | ATx201 Placebo Gel | two hundred microliters (200 μL) of placebo applied to the test site areas of the upper outer arms |
Timeline
- Start date
- 2018-01-08
- Primary completion
- 2018-02-17
- Completion
- 2018-03-15
- First posted
- 2017-12-18
- Last updated
- 2018-05-07
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT03375957. Inclusion in this directory is not an endorsement.